FXGENOMICS - Trademark Details
Status: 602 - Abandoned-Failure To Respond Or Late Response
Image for trademark with serial number 78040644
Serial Number
78040644
Word Mark
FXGENOMICS
Status
602 - Abandoned-Failure To Respond Or Late Response
Status Date
2002-12-30
Filing Date
2000-12-26
Mark Drawing
1000 - Typeset: Word(s)/letter(s)/number(s) Typeset
Published for Opposition Date
2001-08-07
Law Office Assigned Location Code
M30
Employee Name
BLANDU, FLORENTINA
Statements
Goods and Services
Pharmaceutical preparations, namely, targeting transcription factors, growth factors, receptors, and integrins with small molecules such as antisense oligonucleotides and others to block progression of diseases such as cancer
Classification Information
International Class
5 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2001-01-10
Primary Code
005
First Use Anywhere Date
2002-01-23
First Use In Commerce Date
2002-01-23
Correspondences
Name
J SUZANNE LINDSEY
Address
Please log in with your Justia account to see this address.
Trademark Events
Event DateEvent Description
2001-05-17ASSIGNED TO EXAMINER
2001-05-21APPROVED FOR PUB - PRINCIPAL REGISTER
2001-07-25NOTICE OF PUBLICATION
2001-08-07PUBLISHED FOR OPPOSITION
2001-10-30NOA MAILED - SOU REQUIRED FROM APPLICANT
2002-04-12TEAS STATEMENT OF USE RECEIVED
2002-04-12USE AMENDMENT FILED
2002-04-17STATEMENT OF USE PROCESSING COMPLETE
2002-05-01NON-FINAL ACTION MAILED
2002-12-30ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE